Xin Yi Chen

US Patent:

8111957, Feb 7, 2012

Filed:

Jul 7, 2009

Appl. No.:

12/498591

Inventors:

Robert R Alfano - Bronx NY, US
Xin Chen - Corning NY, US
Joohyun Koh - Painted Post NY, US
Ming-Jun Li - Horseheads NY, US
Daniel Aloysius Nolan - Corning NY, US
Henry Sztul - New York NY, US

Assignee:

Corning Incorporated - Corning NY

International Classification:

G02B 6/26
G01N 21/00

US Classification:

385 28, 356 731

Abstract:

Generation of a cylindrically polarized light beam, and in particular, a hybrid-azimuthal-radial polarization beams, called HARP modes, generated from an input linearly polarized Gaussian beam using a spun optical waveguide device is taught. The HARP modes are comprised of hybrid-azimuthal polarization (HAP) and hybrid-radial polarization (HRP) superposition modes. These beams possess a non-zero local angular momentum density that is spatially varying and a zero total angular momentum.

US Patent:

20090305960, Dec 10, 2009

Filed:

Jun 8, 2009

Appl. No.:

12/480420

Inventors:

Xin Chen - Furlong PA, US
Shubh D. Sharma - Cranbury NJ, US
Yi-Qun Shi - East Brunswick NJ, US
Wei Yang - Edison NJ, US

Assignee:

Palatin Technologies, Inc - Cranbury NJ

International Classification:

A61K 38/12
C07K 7/64
A61P 3/00

US Classification:

514 11, 530321

Abstract:

Melanocortin receptor-specific cyclic peptides of the formulawhere R, R, R, R, x and y are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, diabetes, modulation of feeding behavior and related metabolic syndrome.

US Patent:

20120077957, Mar 29, 2012

Filed:

Dec 6, 2011

Appl. No.:

13/311817

Inventors:

Xin Chen - Furlong PA, US
Wei Yang - Edison NJ, US

Assignee:

PALATIN TECHNOLOGIES, INC. - Cranbury NJ

International Classification:

C07K 7/54

US Classification:

530323

Abstract:

Lactam-bridged melanocortin receptor-specific cyclic peptides of the formulawhere R, R, R, R, R, R, R, Rand Rare as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes, including obesity, modulation of feeding behavior, related metabolic syndrome, sexual dysfunction, male erectile dysfunction and female sexual dysfunction.

US Patent:

20120178701, Jul 12, 2012

Filed:

Dec 6, 2011

Appl. No.:

13/311824

Inventors:

Yi-qun Shi - East Brunswick NJ, US
Shubh D. Sharma - Cranbury NJ, US
John H. Dodd - Flemington NJ, US
Wei Yang - Edison NJ, US
Xin Chen - Furlong PA, US

Assignee:

PALATIN TECHNOLOGIES, INC. - Cranbury NJ

International Classification:

A61K 38/12
A61P 3/00
A61P 3/04
A61P 15/00
C07K 7/54
A61P 15/10

US Classification:

514 206, 530317, 514 211

Abstract:

Melanocortin receptor-specific cyclic peptides of the formulawhere R, R, R, R, R, R, R, R, R, Rand z are as defined in the specification, compositions and formulations including the peptides of the foregoing formula, and methods of preventing, ameliorating or treating melanocortin receptor-mediated diseases, indications, conditions and syndromes.

US Patent:

20130231306, Sep 5, 2013

Filed:

Jan 25, 2013

Appl. No.:

13/749758

Inventors:

Dan Sherman - New York NY, US
Rama Devi Appari - Port Jefferson Station NY, US
Xin Chen - Commack NY, US
Ramesh Chilukuri - Budha Nagar near Uppal Depot NY, US
Hanqing Dong - Syosset NY, US
Caterina Ferraro - Fresh Meadows NY, US
Kenneth Foreman - Syosset NY, US
Ramesh C. Gupta - Port Jefferson Station NY, US
An-Hu Li - Commack NY, US
Kathryn M. Stolz - Williston Park NY, US
Brian Volk - Sayville NY, US
Robert Zahler - Pennington NJ, US

Assignee:

OSI Pharmaceuticals, LLC - Farmingdale NY

International Classification:

C07F 9/6558
C07F 9/6544
C07F 9/6512

US Classification:

514 81, 544232, 514 86, 544105, 544 57, 514 80, 514 82

Abstract:

Compounds of Formula 1, as shown below and defined herein:

US Patent:

20220411860, Dec 29, 2022

Filed:

Jul 12, 2021

Appl. No.:

17/373295

Inventors:

Jingyue Ju - Englewood Cliffs NJ, US
Xiaoxu Li - New York NY, US
Xin Chen - New York NY, US
Zengmin Li - Flushing NY, US
Shiv Kumar - Belle Meade NJ, US
Shundi Shi - Ozone Park NY, US
Cheng Guo - Brooklyn NY, US
Jianyi Ren - New York NY, US
Minchen Chien - Tenafly NJ, US
Chuanjuan Tao - Fort Lee NJ, US
Ece Erturk - New York NY, US
Sergey Kalachikov - Bronx NY, US
James J. Russo - New York NY, US

Assignee:

The Trustees of Columbia University in the City of New York - New York NY

International Classification:

C12Q 1/6869
C07H 19/10
C07H 19/14
C07H 19/20

Abstract:

Disclosed herein, inter alfa, are compounds, compositions, and methods of use thereof in the sequencing of a nucleic acid.

US Patent:

20220218719, Jul 14, 2022

Filed:

May 15, 2020

Appl. No.:

17/610531

Inventors:

- Brentford, Middlesex, GB
Xin CHEN - Collegeville PA, US
Rennan PAN - Collegeville PA, US

International Classification:

A61K 31/553
A61K 9/20
A61P 17/06

Abstract:

The present invention relates to modified release pharmaceutical compositions of a RIP1 kinase inhibitor compound and forms thereof, processes or methods of composition preparation and uses or treatment methods therefor.

US Patent:

20230028388, Jan 26, 2023

Filed:

Aug 1, 2022

Appl. No.:

17/816555

Inventors:

- New York NY, US
Xiaoxu Li - New York NY, US
Xin Chen - New York NY, US
Zengmin Li - Flushing NY, US
Shiv Kumar - Belle Meade NJ, US
Shundi Shi - Ozone Park NY, US
Cheng Guo - Brooklyn NY, US
Jianyi Ren - New York NY, US
Minchen Chien - Tenafly NJ, US
Chuanjuan Tao - Fort Lee NJ, US
Ece Erturk - New York NY, US
Sergey Kalachikov - Bronx NY, US
James J. Russo - New York NY, US

Assignee:

The Trustees of Columbia University in the City of New York - New York NY

International Classification:

C12Q 1/6869
C07H 19/10
C07H 19/20
C07H 19/14

Abstract:

Disclosed herein, inter alia, are compounds, compositions, and methods of use thereof in the sequencing of a nucleic acid.